|
you are at the very beginning of a long journey.. herceptin.. is for her2 +++ breast cancer.. you are being treated in the initial stages.. newly diagnosed..
the tras-dm1, tdm1, super herceptin, etc is currently only is phase trials prior to actual approval.. in a few years it will be likely approved at the beginning of the journey , instead of the so late in the game is it is today.
tdm1 is available to patients in a phase 2 and soon phase 3 drug study format. you are evaluated against the current standard of care.
in the metastatic setting..
the two phase 2 trials running currently are 3rd line after tykerb/xeloda failure.
and phase 2.... 1st line tras-dm1 vs herceptin / taxotere
robin.. this forum.. is a fabulous resource for patients. please contribute whenever you can..
run
|